PharmChem (PCHM) Stock Price, News & Analysis

Company Overview

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

Key Stats

• Today's Range: $2.97 to $2.97
• 50-Day Range: $2.97 to $3.40
• 52-Week Range: $2.51 to $4.00
• Volume: 2 shs
• Average Volume: 6,475 shs
• Market Capitalization: $13.80 million
• P/E Ratio: 10.24
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PharmChem Stock Analysis - MarketRank™

PharmChem scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for PharmChem.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of PharmChem is 10.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.18.

Price to Earnings Ratio vs. Sector

The P/E ratio of PharmChem is 10.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.14.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of PharmChem has been sold short.

Short Interest Ratio / Days to Cover

PharmChem has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

PharmChem does not currently pay a dividend.

Dividend Growth

PharmChem does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of PharmChem is 275.86%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of PharmChem has been sold short.

Short Interest Ratio / Days to Cover

PharmChem has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

PharmChem has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for PharmChem this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PharmChem insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.40% of the stock of PharmChem is held by insiders. A high percentage of insider ownership can be a sign of company health.

PCHM Stock Analysis - Frequently Asked Questions

How have PCHM shares performed this year?

PharmChem's stock was trading at $3.06 at the beginning of the year. Since then, PCHM shares have decreased by 2.9% and is now trading at $2.97.
View the best growth stocks for 2025 here.

How were PharmChem's earnings last quarter?

PharmChem, Inc. (OTCMKTS:PCHM) announced its quarterly earnings data on Friday, May, 9th. The company reported $0.06 earnings per share (EPS) for the quarter. The business had revenue of $1.58 million for the quarter.

How do I buy shares of PharmChem?

Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/09/2025
• Today: 5/11/2025
• Next Earnings (Estimated): 5/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:PCHM
• CIK: N/A
• Web: www.pharmchek.com
• Phone: (855) 458-4100
• Fax: 817-605-6400
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.29
• Trailing P/E Ratio: 10.24
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $850,000.00
• Net Margins: 23.32%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.01 million
• Price / Sales: 2.30
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,648,000
• Free Float: 3,839,000
• Market Cap: $13.80 million
• Optionable: Not Optionable
• Beta: 0.73